Danish enzyme producer Novozymes' new growth strategy, "Unlocking Growth – Powered by Biotech", stretching to the end of 2025, will pull the company out of an unfortunate trend, says Chief Executive Ester Baiget during the company's virtual capital markets day on Tuesday.
"We haven't met our targets in six years. One year is a point, two years is a line – but three years is a trend," she says about recent years' developments at Novozymes.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for EnergyWatch has now started
With your free trial you get:
Full access to all locked articles on EnergyWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.